What is the first treatment tried for neuroendocrine tumours?

Neuroendocrine tumours arise in different organs and can grow slowly or more quickly. A pathology report describes the tumour type and grade, while scans show its location and whether it has spread. Blood or urine tests may help assess hormones or substances released by the tumour.

When a tumour is localised and removable, tumour removal surgery may be considered first. For disease that has spread or cannot be removed safely, targeted therapy or targeted radioisotope therapy may be appropriate for selected tumours. Treatment can also aim to control hormone-related symptoms as well as tumour growth.

Ask whether the pathology report includes the grade and whether specialist review is needed. Bring imaging reports and a list of symptoms, medicines, and supplements. Mention flushing, wheezing, diarrhoea, abdominal cramps, changes in blood sugar, or episodes of dizziness, because hormone effects may influence preparation.

Your team may check organ function and hormone markers before choosing treatment. If surgery is planned, ask about the operation and recovery. If a targeted medicine or radioisotope is proposed, ask how it recognises tumour cells and how normal organs will be monitored.

Seek urgent medical advice for severe abdominal pain, repeated vomiting, fainting, confusion, chest discomfort, severe wheezing, heavy bleeding, or inability to keep fluids down. A sudden episode of flushing with breathing difficulty or marked dizziness needs prompt assessment. Follow the emergency plan from your oncology team, particularly if hormone symptoms are already known.

What are the tumour site, grade, and hormone features? Can surgery remove it safely? If not, why is targeted therapy or radioisotope therapy suitable? How will symptoms and treatment response be monitored?